€51.20
1.73% today
Xetra, Dec 30, 02:05 pm CET
ISIN
DE000SHL1006
Symbol
SHL

Siemens Healthineers Target price 2024 - Analyst rating & recommendation

Siemens Healthineers Classifications & Recommendation:

Buy
83%
Hold
17%

Siemens Healthineers Price Target

Target Price €59.54
Price €51.20
Potential 16.29%
Number of Estimates 18
18 Analysts have issued a price target Siemens Healthineers 2025 . The average Siemens Healthineers target price is €59.54. This is 16.29% higher than the current stock price. The highest price target is €66.00 28.91% , the lowest is €49.00 4.30% .
A rating was issued by 18 analysts: 15 Analysts recommend Siemens Healthineers to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Siemens Healthineers stock has an average upside potential 2025 of 16.29% . Most analysts recommend the Siemens Healthineers stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029


Sep '24 2025
Estimates
Revenue Billion € 22.36 23.64
3.15% 5.69%
EBITDA Margin 20.23% 21.33%
9.70% 5.46%
Net Margin 8.71% 9.83%
24.95% 12.88%

16 Analysts have issued a sales forecast Siemens Healthineers 2025 . The average Siemens Healthineers sales estimate is €23.6b . This is 5.69% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €24.3b 8.57% , the lowest is €23.3b 4.09% .

This results in the following potential growth metrics:

Revenue Estimates

2024 €22.4b 3.15%
2025 €23.6b 5.69%
2026 €25.1b 6.10%
2027 €26.6b 6.00%
2028 €28.3b 6.44%
2029 €30.5b 7.78%

16 Analysts have issued an Siemens Healthineers EBITDA forecast 2025. The average Siemens Healthineers EBITDA estimate is €5.0b . This is 9.32% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €5.5b 20.26% , the lowest is €4.5b 1.63% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 €4.5b 13.16%
2025 €5.0b 11.45%
2026 €5.6b 10.70%
2027 €6.1b 10.18%
2028 €6.5b 6.53%
2029 €7.3b 12.19%

EBITDA Margin

2024 20.23% 9.70%
2025 21.33% 5.46%
2026 22.25% 4.31%
2027 23.13% 3.96%
2028 23.15% 0.09%
2029 24.09% 4.06%

11 Siemens Healthineers Analysts have issued a net profit forecast 2025. The average Siemens Healthineers net profit estimate is €2.3b . This is 19.32% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.5b 26.44% , the lowest is €2.2b 11.81% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 €1.9b 28.89%
2025 €2.3b 19.32%
2026 €2.8b 20.66%
2027 €3.1b 11.05%
2028 €3.3b 7.02%
2029 €3.4b 1.44%

Net Margin

2024 8.71% 24.95%
2025 9.83% 12.88%
2026 11.18% 13.73%
2027 11.71% 4.74%
2028 11.78% 0.60%
2029 11.08% 5.94%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029


Sep '24 2025
Estimates
Earnings Per Share 1.74 2.08
28.89% 19.54%
P/E 25.09
EV/Sales 3.04

11 Analysts have issued a Siemens Healthineers forecast for earnings per share. The average Siemens Healthineers <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is €2.08 . This is 19.54% higher than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is €2.20 26.44% , the lowest is €1.95 12.07% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 €1.74 28.89%
2025 €2.08 19.54%
2026 €2.51 20.67%
2027 €2.78 10.76%
2028 €2.98 7.19%
2029 €3.02 1.34%

P/E ratio

Current 30.00 23.94%
2025 25.09 16.37%
2026 20.80 17.10%
2027 18.73 9.95%
2028 17.50 6.57%
2029 17.25 1.43%

Based on analysts' sales estimates for 2025, the Siemens Healthineers stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 3.04 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 2.47 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.21 6.41%
2025 3.04 5.25%
2026 2.87 5.75%
2027 2.70 5.66%
2028 2.54 6.05%
2029 2.36 7.22%

P/S ratio

Current 2.61 4.65%
2025 2.47 5.38%
2026 2.33 5.76%
2027 2.19 5.66%
2028 2.06 6.05%
2029 1.91 7.22%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today